Journal Mobile Options
Table of Contents
Vol. 37, No. 2, 2000
Issue release date: February 2000
Eur Urol 2000;37:172–175

Increased Nitric Oxide Production in the Spermatic Vein of Patients with Varicocele

Ozbek E. · Turkoz Y. · Gokdeniz R. · Davarci M. · Ozugurlu F.
Departments of aUrology, bOstetrics and Gynecology, and cBiochemistry, Inonu University School of Medicine, Malatya, Turkey

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objective: To define the level of nitric oxide (NO) in the spermatic vein of patients with varicocele and its relation with male infertility.

Materials and Methods: Following physical and color Doppler ultrasonographic examination, whole blood samples were drawn from a peripheral vein and a dilated varicocele vein from fourteen patients with clinically palpable varicocele (G2–3) before ligation. NO levels in the serum were determined as total nitrite by Greiss reaction and results were compared with Mann–Whitney U test.

Results: NO levels in the internal spermatic vein were 36.05 ± 8.92 μmol/l, compared to 19.41 ± 4.12 μmol/l in the peripheral vein and the difference was statistically significant (p < 0.01).

Conclusion: In view of our results, increased NO levels in the dilated varicocele vein might be responsible for spermatozoa dysfunction.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Greenberg SM: Varicocele and male infertility. Fertil Steril 1977;28:699.
  2. Schlesinger MH, Wilets IF, Nagler HM: Treatment outcome after varicocelectomy: A critical analysis. Urol Clins N Am 1994;21:517.
  3. Chakraborty J, Hikim AP, Jhunjhunwala JS: Stagnation of blood in the microcirculatory vessels in the testes of men with varicocele. J Androl 1985;6:117.

    External Resources

  4. Cohen MS, Plaine L, Brown JS: The role of internal spermatic vein plasma catecholamine determination in subfertile men with varicocele. Fertil Steril 1975;26:1243.

    External Resources

  5. Goldstein M, Eid JF: Elevation of intratesticular and scrotal temperature in men with varicocele. J Urol 1989;142:743.

    External Resources

  6. Ross JA, Watson NE Jr, Jarrow JP: The effect of varicoceles on testicular blood flow in man. Urology 1994;44:535.
  7. Swerdloff RS, Walsh PC: Pituitary and gonadal hormone in patients with varicocele. Fertil Steril 1975;26:1006.

    External Resources

  8. Marinella R, Raghvendra KD, Bruno I, Ervin M, Paul JK: Effects of nitric oxide on human spermatozoa: evidence that nitric oxide decreases sperm motility and induces sperm toxicity. Hum Reprod 1995;10:1786.
  9. Weinberg JB, Doty E, Bonaventura J, Haney AF: Nitric oxide inhibition of human sperm motility. Fertil Steril 1995;64:408–413.

    External Resources

  10. Dionisios M, George D, Anastasios Z, Vassiliki V, Constantinos D, John S: Nitric oxide synthase and xanthine oxidase activities in the spermatic vein of patients with varicocele: A potential role for nitric oxide and peroxynitrite in sperm dysfunction. J Urol 1996;156:1952.
  11. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109.
  12. Moro MA, Darley–Usmar V, Goodwin DA, Read NG, Zamora–Pino R, Feelisch M, Radomski MW, Moncada S: Paradoxical fate and biological action of peroxinitrite on human platelet. Proc Natl Acad Sci USA 1994;91: 6702–6706.
  13. Morris SM, Billar TR: New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 1994;266:E829–E839.

    External Resources

  14. Yallampalli C, Izumi H, Byam–Smith M, Garfield RE: An L–arginine–nitric–oxide–cyclic guanosine monophosphate system exists in the uterus and inhibits uterine contractility during pregnancy. Am J Obstet Gynecol 1993;170: 175–185.
  15. Rosselli M, Imthurn B, Macas E, Keller PJ, Dubey RK: Endogenous nitric oxide modulate endothelin–1 induced contraction of bovine oviduct. Biochem Biophys Res Commun 1994;201:143–146.
  16. Ochoa JB, Udekwu OA, Billiar TR, Curran RB, Simmsons RL, Peitzman AB: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991;214:612–626.
  17. Hibbs JB Jr, Traintor RR, Vavrin Z, Granger DI, Drapier JC, Amber IJ, Lancester JR Jr: Synthesis of nitric oxide from a terminal guanidine nitrogen atom of L–arginine: A molecular mechanism regulating cellular proliferation that targets intracellular iron; in Moncada S, Higgs EA (eds): Nitric Oxide from L–Arginine: A Bioregulator System. Amsterdam, Elsevier, 1990, pp 189–223.
  18. Becmann JS, Becmann TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620– 1624.
  19. Griffith OW, Stuehr DJ: Nitric oxide synthases: Properties and catalytic mechanism. Ann Rev Physiol 1995;57:707.
  20. Gross SS, Wolin MS: Nitric oxide: Pathophysiological mechanisms. Ann Rev Physiol 1995;57:737.
  21. Furchgott RF, Vanhoute PM: Endotheliumderived relaxing and contracting factors. FASEB J 1989;3:2007–2018.
  22. Dawson VL, Dawson TM, London ED, Bredt DS, Synder SH: Nitricoxide mediating glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 1991;88: 6368–6371.
  23. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannen–Baum SR: DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992;89:3030–3034.
  24. Arroyo PL, Hatch–Pigott V, Mower HF, Cooney RV: Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat Res 1992; 136:193–202.
  25. Wink DA, Laval J: The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo. Carcinogenesis 1994;15:2125–2129.

    External Resources

  26. Pryor WA: In Yagi K (ed): Lipid Peroxides in Biology and Medicine. New York, Academic Press, 1982, pp 1–22.
  27. Cotton FA, Wilkinson G: Advanced Inorganic Chemistry, ed 5. New York, Wiley, 1988.
  28. Van der Vliet A, Eiserch JP, O’Neill CA, Halliwell B, Cross CE: Tyrosine modification by reactive nitrogen species: A closer look. Arch Biochem Biophys 1995;319:341.
  29. Hellstrom WJG, Bell M, Wang R, Sikka SC: Effect of sodium nitroprusside on sperm motility, viability and lipid peroxidation. Fertil Steril 1994;61:1117–1122.
  30. Chan YM, Chan SY, Tucker MJ, Wong CJ, Leung CK, Leong MK: Effects of dibutyryl cyclic guanosine monophosphate on human spermatozoa motility and penetration of zonafree hamster oocyte. Hum Reprod 1990;5: 304–308.
  31. Mitchell JA, Nelson L, Hafez ESE: Motility of spermatozoa; in Hafez ESE (ed): Human Semen and Fertility Regulation in Men. St. Louis, Mosby, 1976, pp 83–99.
  32. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051– 3064.
  33. Kostic T, Andrich S, Kovacevic R, Maric D: The involvement of nitric oxide in stress impaired testicular steroidogenesis. Eur J Pharmacol 1998;346:267–273.

    External Resources

  34. Pomerantz DK, Pitelka V: Nitric oxide is a mediator of the inhibitory effect of activated macrophages on production of androgen by the Leydig cell of the mouse. Endocrinology 1998; 139:922–931.

Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00